The SNSS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the SNSS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The SNSS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View SNSS Detailed Price Forecast - CNN Money||View SNSS Detailed Summary - Google Finance|
|View SNSS Detailed Summary - Yahoo! Finance||View SNSS Stock Research & Analysis - Zacks.com|
|View SNSS Trends & Analysis - Trade-Ideas||View SNSS Major Holders - Barrons|
|View SNSS Call Transcripts - NASDAQ||View SNSS Breaking News & Analysis - Seeking Alpha|
|View SNSS Annual Report - CompanySpotlight.com||View SNSS OTC Short Report - OTCShortReport.com|
|View SNSS Fundamentals - TradeKing||View SNSS SEC Filings - Bar Chart|
|View Historical Prices for SNSS - The WSJ||View Performance/Total Return for SNSS - Morningstar|
|View the Analyst Estimates for SNSS - MarketWatch||View the Earnings History for SNSS - CNBC|
|View the SNSS Earnings - StockMarketWatch||View SNSS Buy or Sell Recommendations - MacroAxis|
|View the SNSS Bullish Patterns - American Bulls||View SNSS Short Pain Metrics - ShortPainBot.com|
|View SNSS Stock Mentions - StockTwits||View SNSS Stock Mentions - PennyStockTweets|
|View SNSS Stock Mentions - Twitter||View SNSS Investment Forum News - Investor Hub|
|View SNSS Stock Mentions - Yahoo! Message Board||View SNSS Stock Mentions - Seeking Alpha|
|View Insider Transactions for SNSS - SECform4.com||View Insider Transactions for SNSS - Insider Cow|
|View SNSS Major Holdings Summary - CNBC||View Insider Disclosure for SNSS - OTC Markets|
|View Insider Transactions for SNSS - Yahoo! Finance||View Institutional Holdings for SNSS - NASDAQ|
|View SNSS Stock Insight & Charts - FinViz.com||View SNSS Investment Charts - StockCharts.com|
|View SNSS Stock Overview & Charts - BarChart||View SNSS User Generated Charts - Trading View|
Sunesis Pharmaceuticals Strengthens Senior Management Team
Posted on Monday July 09, 2018
Sunesis Pharmaceuticals, Inc. (SNSS) today announced three key new management appointments as part of the Company’s expansion of its development team. Deepali Suri, M.Sc., a former Executive Director at Pharmacyclics (an AbbVie Company), was appointed Vice President, Clinical Operations, and Sean Gharpurey, M.S., MBA, joined as Executive Director, Project Management. Stephen Nava was promoted to Vice President, Quality Assurance, Compliance and Regulatory Affairs.
Sunesis Pharmaceuticals Enters into $15.5 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC
Posted on Monday June 25, 2018
Sunesis Pharmaceuticals, Inc. (SNSS) today announced that it has entered into a Common Shares Purchase Agreement (the “Agreement”) of up to $15.5 million with Aspire Capital Fund, LLC (“Aspire Capital”). Under the terms of the Agreement, Aspire Capital has made an initial investment via purchase of $500,000 worth of SNSS common shares at a price of $2.19 per common share. In addition, Aspire Capital has committed to purchasing up to an additional $15 million of common shares of Sunesis, at Sunesis’ request from time to time during a 24-month period beginning on the effective date of a registration statement related to the transaction and at prices based on the market price at the time of each sale.
Sunesis Pharmaceuticals Announces Presentations at the EHA Annual Meeting
Posted on Monday June 18, 2018
Université Claude Bernard de Lyon Study Provides Preclinical Validation of Vecabrutinib Activity Against Ibrutinib-Resistant BTK C481S Mutated Lymphomas. ERIC Study Shows Half of Ibrutinib-Relapse CLL ...
5 Biotech Stocks Under $10 Worthy of Investors' Attention
Posted on Friday June 15, 2018
Small biotech stocks are good bets with lower market cap as well as share price.